Because its biological halflife is so long (-50 days), the drug can be conveniently administered once daily. There is no defined therapeutic range of its concentration in serum, so dosages of amiodarone have been chosen empirically, which may account for the frequent and numerous side effects reported with this drug (1, 2) . For maximal therapeutic effects and minimized undesirable side effects, monitoring the drug concentration may be necessary.
Materials and Methods

Apparatus.
We used a Milton Roy minipump (Laboratory Data Control, Riviera Beach, FL 33404), a Model 7125 injector (Rheodyne, Inc., Cotati, CA 94928), and a Model 440 ultraviolet detector and a 15 cm x 3.9 mm Resolve 5-sm Spherical Silica column (both from Waters Associates, Milford, MA 01757).
Reagents. "HPLC-grade" methanol was from Burdick & Jackson Laboratory, Inc., Muskegon, MI 49442. Isopropyl ether was from Aldrich Chemical Co., Milwaukee, WI 53200. Ammonium sulfate buffer (17 minolfL) was prepared by dissolving 2.2 g of (NH4)2S04 in 1 L of doubly distilled water, then filtering it through a 0.45-sm (pore size) Millipore filter (Millipore Corp., Bedford, MA 01730) and adjusting the pH to 6.8 with a 1 moIJL solution of NaOH. The mobile phase, 920 mL of methanol and 80 mL of ammonium sulfate buffer, was degassed with helium for 10 miii before use. Phosphate buffer (0.36 moIJL, pH 4.35) for extraction was prepared by dissolving 4.32 g of NaH2PO4 in 100 mL of doubly distilled water.
Standards.
Amiodarone hydrochloride, N-desethylamiodarone hydrochloride, and the internal standard, L8040 [2-ethyl-3-(3,5-dibromo-4y-dipropylaminopropoxybenzoyl)-benzothiophene}, were kindly provided by Sanofi, Montpellier, France. The working standards of anuodarone and N-desethylamiodarone (1.0 and 2.5 mg/L) were prepared by diluting the stock 1 g/L methanolic solutions of the drugs with plasma. The internal standard was 6 mg of L8040 dissolved in 1 L of methanol.
Assay procedure.
Add 250 4 of serum, standard, or control; 100 4 of 0.36 mol/L NaH2PO4 buffer; 100 4 of internal standard;
and 200 4 of isopropyl ether to a 1.5-mL polypropylene test tube. Vortex-mix for 30 s and centrifuge at 3000 x g for 3 mm. Inject 50 p.L of the organic (top) layer onto the column and elute with mobile phase at the rate of 1.8 mb/mimi at ambient temperature. The column effluent is monitored at 254 mm with the detector set at 0.02 A full scale.
Other procedures. For comparison, we measured amiodarone and N-desethylanuodarone by a normal-phase HPLC method as described by Kane and Shaw (9).
The absolute-recovery study was performed by adding amiodarone and N-desethylamiodarone to methanol and to drug-free plasma. We then extracted the plasma samples by the regular extraction procedure described above. All extracted (plasma) and unextracted (methanol) samples were injected onto the column in triplicate. Peak heights of the extracted samples were compared with those of the unextracted samples to determine absolute recovery.
For the interference study, we tested fiecainide acetate, propranolol, indomethacin, digoxin, and lidocaine. These were dissolved in the appropriate solvent and added to a specimen containing amiodarone and N-desethylamiodarone. Other drugs tested for interference were those contained in Level ifi TDM control material (Ciba Corning Diagnostic Corp., Irvine, CA 92714), to which amiodarone and N-desethylamiodarone were added. Specimens containing amiodarone and N-desethylamiodarone are stable for at least 90 days if stored at 4.-S #{176}C. However, N-desethylamiodarone tends to increase when specimens are stored at room temperature for longer than five days.
Results
Discussion
Conventionally, when a normal-phase chromatographic method is used to separate amiodarone from its metabolite, the amiodarome is eluted from the column earlier than the internal standard and N-desethylamiodarone, as shown in the method of Kane and Shaw (9). By substituting the ammonium sulfate for ammonium phosphate in the mobile phase, the eluting sequence of amiodarone and N-desethylamiodarome is reversed, as shown in Figure 1 . That sulfate salt may play an important role in this reversal is evidenced by a different normal-phase procedure (10) in which sulfuric acid was used.
There are several advantages of using these chromatographic conditions. The baseline resolution of each compound is excellent and therefore quantification is accurate. The chromatographic conditions are very stable in that there is little day-to-day change in retention times. The long durability of the column (more than 1500 injections per column) and the ability to recycle the mobile phase make this an economical procedure for use in the clinical laboratory. The same column and pump can be used for fiecaimde acetate and propranolol analyses by simply equilibrating the column for 15 miii in a flecainide mobile phase that is very similar to that of the amiodarone assay (11). Finally, the same chromatographic conditions to measure amiodarone in serum can also be used to measure amiodarone in tissue. Tissue samples obtained from myocardium, lung, adipose, skeletal muscle, etc., were wrapped in plastic wrap, pounded into thin layers, frozen, lyophilized, pulverized, and weighed. The powdered tissues were then extracted into a measured amount of isopropyl ether/methanol mixture (50/50 by vol). Amiodarone and N-desethylamiodarone were quantified by mixing the supernate with internal standard and comparing the peakarea ratio with that of standards prepared in the same solvent matrix. Tissue samples from a patient receiving no amiodarone showed no peaks with retention times similar to amiodarone, N-desethylamiodarone, or the internal standard.
This method has been used in our laboratory for the last four years for analyses of thousands of serum samples and numerous tissue samples, and we have encountered no significant interferences. The simplicity of the extraction, the durability of the column, and the adaptability of the chromatographic system provide an efficient, cost-effective way of increasing therapeutic drug monitoring services with little additional expense. 
Effect of Serum Lyophilization on the Rate Constants of Enzymatic Methods for Measuring Cholesterol
MartIn H. Kroll and Ruth Cheeler
We determined the equilibrium absorbances and rate constants for two enzymatic methods, aca (DuPont) and RA-1000 (Technicon), used in determining cholesterol in reconstituted lyophilized serum. The lyophilized materials included two serum pools, three control materials, a Colloge of American Pathologists' survey material, and Standard Reference Material no. 909. We calibrated the reagents with aca standards for cholesterol (DuPont). The difference in the mean concentrations of cholesterol (aca -RA-1 000) was -0.09 g/L overall and was not statistically significant by analysis of variance. The mean rate constant for all materials was 0.23 min1 for the aca and 1.42 min1 for the RA-1000, significantly different (P <0.001). Lyophilization causes lower results for the aca method than for the RA-1 000, because the reaction rate for the aca method is slower and has not reached equilibrium when the final absorbance reading is made. Bias varies among methods. For example, the RA-1000 has essentially no bias, whereas the aca has a bias of >4% (6). Further, cholesterol results for lyophilized materials determined with the aca are lower than those determined with the RA-1000, whereas the results for serum samples determined with the aca are higher than those determined with the RA-1000 (6). In a study comparing the results of lyophilized vs frozen serum poois, the RA-1000 results were 1.7% lower and the aca results 14.3% lower for the lyophilized serum (8). Lyophilization of serum does affect the results obtained with different enzymatic methods for determining cholesterol, but the reason is not apparent. The RA-1000 and aca methods for determining cholesterol represent two extremes for the lyophilization effect. In this study, we compared the equilibrium absorbance and the rate of reaction for the RA-1000 and aca methods.
Materials and Methods
Apparatus.
We used the Lambda 4B High Performance Spectrophotometer (Perkin-Elmer Analytical Instruments, Norwalk, CT 06856).
Reagents. We used two sets of reagents to determine cholesterol: those for the RA-1000 (Technicon Instruments Corp., Tarrytown, NY 10591) and for the aca (DuPont Co., Clinical Systems Division, Wilmington, DE 19898). The aca reagents were cut out of their packs and consolidated on the day of each experiment. To calibrate the reagents at equilibrium, we used aca Standards, Levels 1 through 4
(DuPont).
We tested seven lyophilized materials. Pools A and B were prepared for us and contained no preservatives (8). 
